Takeda: strategic alliance with Canada’s enGene on gene therapy for diseases of the digestive system

enGene has developed „Gene Plii“, an oral, non-viral gene therapy based on chitosan encapsulation which allows a highly flexible nucleotide (DNA and RNAi) delivery to mucosal tissues targeting chronic diseases via the induction or suppression of protein expression levels.

Takeda news release, January 12, 2016

Takeda: strategic alliance with Canada’s enGene on gene therapy for diseases of the digestive system
Scroll to top